Freedom of Information responses from the MHRA - week commencing 12 April 2021

Freedom of Information request on yellow card reports received within the past ten years for Revaxis, MenACWY and Nimenrix (FOI 21-244)

HTML

PDF, 60.7 KB, 32 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 65 KB, 33 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 46.6 KB, 26 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on the Allergan Implant Recall (FOI 21-254)

HTML

Freedom of Information request on adverse reactions to influenza vaccines (FOI 21-257)

HTML

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 148 KB, 61 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 70.4 KB, 35 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on Summaries of Product Characteristics (SmPCs) and Patient Information Leaflets (PILs) for any vaccine that is currently authorised (FOI 21-258)

HTML

Freedom of Information request on adverse reactions to named vaccines (FOI 21-259)

HTML

Freedom of Information request on adverse reactions observed to vaccine treatment (FOI 21-261)

HTML

Freedom of Information request on adverse reactions to COVID-19 vaccines from Northern Ireland (FOI 21-265)

HTML

Freedom of Information request about UK spontaneous adverse drug reaction reports concerning e-cigarettes (FOI-21-267)

HTML

PDF, 996 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 229 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 445 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 162 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 166 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 310 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about recruitment (FOI-21-272)

HTML

Freedom of Information request about suspected adverse reactions for Intravenous administration of Venofer to dialysis patients in the UK over the past 10 years (FOI-21-273)

HTML

PDF, 194 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request about ADR side effects reported from the Channel Islands (FOI-21-274)

HTML

Freedom of Information request about the contract register (FOI-21-275)

HTML

Freedom of Information request about authorisation of the Pfizer/BioNTech and the Oxford/AstraZeneca vaccines (FOI-21-285)

HTML

Freedom of Information request on Ernst and Young costs for consulting services (FOI-21-287)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in lateral flow tests (FOI-21-293)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in lateral flow tests (FOI-21-296)

HTML

Freedom of Information request about the Oxford AstraZeneca vaccine (FOI-21-298)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in lateral flow tests (FOI-21-302)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in lateral flow tests (FOI-21-304)

HTML

Freedom of Information request about the authorisation of the Pfizer/BioNTech and the Oxford/AstraZeneca vaccines was done through an expedited rolling review (FOI-21-309)

HTML

Freedom of Information request for information on progress of the market authorisation of the Novavax vaccination (FOI-21-317)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in lateral flow tests (FOI-21-318)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in lateral flow tests (FOI-21-320)

HTML

Freedom of Information request about the MAGEC System (FOI-21-324)

HTML

Freedom of Information request about the quantities of Sorbitol (E420), sodium methyl hydroxybenzoates and propylhydroxybenzoates in the product Glycopyrronium Oral Solution (FOI-21-336)

HTML

Freedom of Information request about study data for the Pfizer/BioNTech vaccine (FOI-21-340)

HTML

Freedom of Information request about Dechoker UK Ltd (FOI-21-346)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in COVID-19 tests (FOI-21-348)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilize the swabs used in lateral flow tests. (FOI-21-354)

HTML

Freedom of Information request about adverse drug reactions (ADR) to Covid-19 vaccines (FOI-21-365)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in lateral flow tests (FOI-21-382)

HTML

Freedom of Information request about the safety of ethylene oxide (EO) and its use to sterilise the swabs used in lateral flow tests (FOI-21-383)

HTML

188体育